Alternative lengthening of telomeres in human cells

Radiation Research

Volumn 155, Issue 1, 2001, Pages 194-200

  Reddel, Roger R ^a   Bryan, Tracy M ^a,b   Colgin, Lorel M ^a   Perrem, Kilian T ^a   Yeager, Thomas R ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL; CELL LINE; CELL TRANSFORMATION; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NEOPLASM; REVIEW; TELOMERE;

ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 0035218603     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0194:ALOTIH]2.0.CO;2     Document Type: Article

References (36)

1. C. W. Greider and E. H. Blackburn, Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413 (1985).
2. C. M. Counter, A. A. Avilion, C. E. LeFeuvre, N. G. Stewart, C. W. Greider, C. B. Harley and S. Bacchetti, Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929 (1992).
3. T. M. Bryan, A. Englezou, J. Gupta, S. Bacchetti and R. R. Reddel, Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248 (1995).
4. P. M. Lansdorp, S. Poon, E. Chavez, V. Dragowska, M. Zijlmans, T. Bryan, R. Reddel, M. Egholm, S. Bacchetti and U. Martens, Telomeres in the hematopoietic system. Ciba Found. Symp. 211, 209-218 (1997).
5. T. R. Yeager, A. A. Neumann, A. Englezou, L. I. Huschtscha, J. R. Noble and R. R. Reddel, Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179 (1999).
6. T. M. Bryan and R. R. Reddel, Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur. J. Cancer 33, 767-773 (1997).
7. J. W. Shay and S. Bacchetti, A survey of telomerase activity in human cancer. Eur. J. Cancer 33A, 787-791 (1997).
8. J. Feng, W. D. Funk, S-S. Wang, S. L. Weinrich, A. A. Avilion, C-P. Chiu, R. R. Adams, E. Chang, R. C. Allsopp and B. Villeponteau, The RNA component of human telomerase. Science 269, 1236-1241 (1995).
9. T. M. Nakamura, G. B. Morin, K. B. Chapman, S. L. Weinrich, W. H. Andrews, J. Lingner, C. B. Harley and T. R. Cech, Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959 (1997).
10. M. Meyerson, C. M. Counter, E. N. Eaton, L. W. Ellisen, P. Steiner, S. D. Caddle, L. Ziaugra, R. L. Beijersbergen, M. J. Davidoff and R. A. Weinberg, hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795 (1997).
11. A. Kilian, D. D. L. Bowtell, H. E. Abud, G. R. Hime, D. J. Venter, P. K. Keese, E. L. Duncan, R. R. Reddel and R. A. Jefferson, Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6, 2011-2019 (1997).
12. L. Harrington, W. Zhou, T. McPhail, R. Oulton, D. S. K. Yeung, V. Mar, M. B. Bass and M. O. Robinson, Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 11, 3109-3115 (1997).
13. T. M. Bryan, L. Marusic, S. Bacchetti, M. Namba and R. R. Reddel, The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet. 6, 921-926 (1997).
14. M. P. Hande, E. Samper, P. Lansdorp and M. A. Blasco, Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144, 589-601 (1999).
15. - senescence. Cell 73, 347-360 (1993).
16. M. J. McEachern and E. H. Blackburn, Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev. 10, 1822-1834 (1996).
17. W. Roth, F. Kobeski, M. F. Walter and H. Biessmann, Chromosome end elongation by recombination in the mosquito Anopheles gambiae. Mol. Cell. Biol. 17, 5176-5183 (1997).
18. O. Danilevskaya, F. Slot, M. Pavlova and M-L. Pardue, Structure of the Drosophila HeT-A transposon: A retrotransposon-like element forming telomeres. Chromosoma 103, 215-224 (1994).
19. H. Biessmann and J. M. Mason, Telomere maintenance without telomerase. Chromosoma 106, 63-69 (1997).
20. J. S. Rhim, Neoplastic transformation of human cells in vitro. Crit. Rev. Oncogen. 4, 313-335 (1993).
21. L. S. Gollahon, E. Kraus, T-A. Wu, S. O. Yim, L. C. Strong, J. W. Shay and M. A. Tainsky, Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts. Oncogene 17, 709-717 (1998).
22. J. Gupta, L-P. Han, P. Wang, B. L. Gallie and S. Bacchetti, Development of retinoblastoma in the absence of telomerase activity. J. Natl. Cancer Inst. 88, 1152-1157 (1996).
23. M. Hodges, C. Tissot, K. Howe, D. Grimwade and P. S. Freemont, Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63, 297-304 (1998).
24. H. de The, C. Lavau, A. Marchio, C. Chomienne, L. Degos and A. Dejean, The PML-RAR alpha fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684 (1991).
25. H. Ogino, K. Nakabayashi, M. Suzuki, E. Takahashi, M. Fujii, T. Suzuki and D. Ayusawa, Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem. Biophys. Res. Commun. 248, 223-227 (1998).
26. Y. Tokutake, T. Matsumoto, T. Watanabe, S. Maeda, H. Tahara, S. Sakamoto, H. Niida, M. Sugimoto, T. Ide and Y. Furuichi, Extrachromosome telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247, 765-772 (1998).
27. J. P. Murnane, L. Sabatier, B. A. Marder and W. F. Morgan, Telomere dynamics in an immortal human cell line. EMBO J. 13, 4953-4962 (1994).
28. R. R. Reddel, T. M. Bryan and J. P. Murnane, Immortalized cells with no detectable telomerase activity. A review. Biochemistry (Mosc.) 62, 1254-1262 (1997).
29. J. D. Griffith, L. Comeau, S. Rosenfield, R. M. Stansel, A. Bianchi, H. Moss and T. de Lange, Mammalian telomeres end in a large duplex loop. Cell 97, 503-514 (1999).
30. K. Perrem, T. M. Bryan, A. Englezou, T. Hackl, E. L. Moy and R. R. Reddel, Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18, 3383-3390 (1999).
31. M. Katoh, M. Katoh, M. Kameyama, H. Kugoh, M. Shimizu and M. Oshimura, A repressor function for telomerase activity in telomerase-negative immortal cells. Mol. Carcinogen. 21, 17-25 (1998).
32. N. W. Kim, M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich and J. W. Shay, Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
33. T. M. Bryan, A. Englezou, L. Dalla-Pozza, M. A. Dunham and R. R. Reddel, Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3, 1271-1274 (1997).
34. J. Wen, Y-S. Cong and S. Bacchetti, Reconstitution of wild-type or mutant telomerase activity in telomerase negative immortal human cells. Hum. Mol. Genet. 7, 1137-1141 (1998).
35. C. Mehle, M. A. Piatyszek, B. Ljungberg, J. W. Shay and G. Roos, Telomerase activity in human renal cell carcinoma. Oncogene 13, 161-166 (1996).
36. C. N. Sprung, T. M. Bryan, R. R. Reddel and J. P. Murnane, Normal telomere maintenance in immortal ataxia telangiectasia cell lines. Mutat. Res. 379, 177-184 (1997).